The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

Authors:
  • RKRobert E. Kalb
    Robert E. Kalb
  • ABAndrew Blauvelt
    Andrew Blauvelt
  • MHMichael P. Heffernan
    Michael P. Heffernan
  • HSHoward L. Sofen
    Howard L. Sofen
  • LFLaura Korb Ferris
    Laura Korb Ferris
  • FKFrancisco A. Kerdel
    Francisco A. Kerdel
  • SCStephen Calabro
    Stephen Calabro
  • JWJim Wang
    Jim Wang
  • MCMarc Chevrier
    Marc Chevrier

Abstract
No abstract available

This publication has 25 references indexed in Scilit: